LACK OF CLINICALLY IMPORTANT INTERACTION BETWEEN ERYTHROMYCIN AND THEOPHYLLINE

被引：16

作者：

HILDEBRANDT, R ^{[1
]}

GUNDERTREMY, U ^{[1
]}

MOLLER, H ^{[1
]}

WEBER, E ^{[1
]}

机构：

[1] ZENTRALLAB DEUTSCH APOTHEKEN,ESCHBORN,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 26卷 / 04期

关键词：

D O I：

10.1007/BF00542146

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：485 / 489

页数：5

共 17 条

[1] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].

BENET, LZ ;

GALEAZZI, RL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074

[2] SECONDARY METABOLISM OF THEOPHYLLINE BIOTRANSFORMATION PRODUCTS IN MAN - ROUTE OF FORMATION OF 1-METHYLURIC ACID [J].

BIRKETT, DJ ;

MINERS, JO ;

ATTWOOD, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (01) :117-119

[3]

BONATI M, 1980, 1ST P WORLD C CLIN P

[4] THE EFFECTS OF ERYTHROMYCIN ON THE ABSORPTION AND DISPOSITION KINETICS OF THEOPHYLLINE [J].

BRANIGAN, TA ;

ROBBINS, RA ;

CADY, WJ ;

NICKOLS, JG ;

UEDA, CT .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) :115-120

[5] STUDIES OF THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN - ORAL VERSUS IV ADMINISTRATION AND THE INFLUENCE OF URINARY COLLECTION TIME [J].

DANHOF, M ;

VANZUILEN, A ;

BOEIJINGA, JK ;

BREIMER, DD .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) :433-441

[6]

HEINZEL G, 1981, PHARMACOKINETICS DRU, P207

[7]

HEMSWORTH CT, 1981, BIOCH PHARM, V30, P1299

[8]

HILDEBRANDT R, 1983, WORLD C CLIN PHARM T

[9] LACK OF EFFECT OF INTRAVENOUS ERYTHROMYCIN LACTOBIONATE ON THEOPHYLLINE CLEARANCE [J].

KIMELBLATT, BJ ;

SLAUGHTER, RL .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1980, 65 (04) :313-314

[10] EFFECTS OF ERYTHROMYCIN ON HEPATIC DRUG-METABOLIZING-ENZYMES IN HUMANS [J].

LARREY, D ;

FUNCKBRENTANO, C ;

BREIL, P ;

VITAUX, J ;

THEODORE, C ;

BABANY, G ;

PESSAYRE, D .

BIOCHEMICAL PHARMACOLOGY, 1983, 32 (06) :1063-1068

← 1 2 →